Functional gene variation in the human norepinephrine transporter - Association with attention deficit hyperactivity disorder

被引:27
|
作者
Kim, Chun-Hyung [1 ]
Waldman, Irwin D. [2 ]
Blakely, Randy D. [3 ,4 ]
Kim, Kwang-Soo [1 ]
机构
[1] Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab, Belmont, MA 02478 USA
[2] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA
[3] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA
来源
MOLECULAR AND BIOPHYSICAL MECHANISMS OF AROUSAL, ALERTNESS, AND ATTENTION | 2008年 / 1129卷
关键词
norepinephrine transporter; promoter; polymorphism; snail family; ADHD;
D O I
10.1196/annals.1417.023
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The norepinephrine (NE) transporter (NET) is responsible for the re-uptake of NE into presynaptic nerve terminals, thus critically regulating noradrenergic signaling and homeostasis. Since NE signaling contributes to diverse brain functions, we hypothesize that promoter variation within the human NET gene (solute carrier family 6, member 2; SLC6A2) may impact risk for NE-related disorders, including depression, attention deficit hyperactive disorder (ADHD), and autonomic dysfunction. In support of this, we recently found a functional polymorphism at -3081 position upstream of the transcription initiation site. This polymorphism displayed differential promoter function, which we showed could arise from recruitment of a transcriptional repressor. Further analyses identified Slug and Scratch as candidates involved in repression of SLC6A2 transcription generated by the -3081(T) allele. Moreover, we observed a significant association of the -3081(T) variant with ADHD. Altered transcription of SLC6A2 may therefore represent a novel risk factor for the development of ADHD.
引用
收藏
页码:256 / 260
页数:5
相关论文
共 50 条
  • [1] Association of norepinephrine transporter gene polymorphisms in attention-deficit/hyperactivity disorder in Korean population
    Oh, So-Young
    Kim, Yong-Ku
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 73 : 56 - 63
  • [2] The norepinephrine transporter gene and attention-deficit hyperactivity disorder
    Barr, CL
    Kroft, J
    Feng, Y
    Wigg, K
    Roberts, W
    Malone, M
    Ickowicz, A
    Schachar, R
    Tannock, R
    Kennedy, JL
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (03): : 255 - 259
  • [3] Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder
    Mazei-Robison, MS
    Couch, RS
    Shelton, RC
    Stein, MA
    Blakely, RD
    NEUROPHARMACOLOGY, 2005, 49 (06) : 724 - 736
  • [4] Association Studies of-3081(A/T) Polymorphism of Norepinephrine Transporter Gene With Attention Deficit/Hyperactivity Disorder in Korean Population
    Joung, Yoosook
    Kim, Chun-Hyung
    Moon, Jisook
    Jang, Won-Seok
    Yang, Jaewon
    Shin, Dongwon
    Lee, Soonyoung
    Kim, Kwang-Soo
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B (02) : 691 - 694
  • [5] DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: No evidence for association
    Xu, XH
    Knight, J
    Brookes, K
    Mill, J
    Sham, P
    Craig, I
    Taylor, E
    Asherson, P
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 134B (01) : 115 - 118
  • [6] Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder
    Doyle, Christopher
    Brookes, Keeley
    Simpson, Jennifer
    Park, Joanne
    Scott, Sarah
    Coghill, David R.
    Hawi, Ziarah
    Kirley, Aiveen
    Gill, Michael
    Kent, Lindsey
    NEUROSCIENCE LETTERS, 2009, 462 (02) : 179 - 181
  • [7] Choline transporter gene variation is associated with attention-deficit hyperactivity disorder
    Brett A. English
    Maureen K. Hahn
    Ian R. Gizer
    Michelle Mazei-Robison
    Angela Steele
    Daniel M. Kurnik
    Mark A. Stein
    Irwin D. Waldman
    Randy D. Blakely
    Journal of Neurodevelopmental Disorders, 2009, 1 : 252 - 263
  • [8] Choline transporter gene variation is associated with attention-deficit hyperactivity disorder
    English, Brett A.
    Hahn, Maureen K.
    Gizer, Ian R.
    Mazei-Robison, Michelle
    Steele, Angela
    Kurnik, Daniel M.
    Stein, Mark A.
    Waldman, Irwin D.
    Blakely, Randy D.
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2009, 1 (04) : 252 - 263
  • [9] Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder
    Hahn, Maureen K.
    Steele, Angela
    Couch, R. Steven
    Stein, Mark A.
    Krueger, Jessica J.
    NEUROPHARMACOLOGY, 2009, 57 (7-8) : 694 - 701
  • [10] Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association
    Rippel, Christopher A.
    Kobets, Andrew J.
    Yoon, Dustin Y.
    Williams, Phillip N.
    Shugart, Yin Yao
    Bridges, Dana D.
    Vandenbergh, David J.
    Singer, Harvey S.
    PSYCHIATRIC GENETICS, 2006, 16 (05) : 179 - 180